0001387131-19-009327.txt : 20191204 0001387131-19-009327.hdr.sgml : 20191204 20191204070027 ACCESSION NUMBER: 0001387131-19-009327 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191203 FILED AS OF DATE: 20191204 DATE AS OF CHANGE: 20191204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEDERMAN SETH CENTRAL INDEX KEY: 0001563420 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36019 FILM NUMBER: 191267333 MAIL ADDRESS: STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP STREET 2: 509 MADISON AVE., SUITE 306 CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp. CENTRAL INDEX KEY: 0001430306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261434750 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 509 MADISON AVE. - SUITE 306 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 1-800-849-7894 MAIL ADDRESS: STREET 1: 509 MADISON AVE. - SUITE 306 CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC. DATE OF NAME CHANGE: 20080320 4 1 lederman-form4_120319.xml OWNERSHIP DOCUMENT X0306 4 2019-12-03 0 0001430306 Tonix Pharmaceuticals Holding Corp. TNXP 0001563420 LEDERMAN SETH C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVENUE, SUITE 1608 NEW YORK NY 10022 1 1 0 0 Chief Executive Officer Common Stock, $0.001 par value 2019-12-03 4 P 0 20000 1.159 A 23267 I By 401(k) plan Common Stock, $0.001 par value 459 I By IRA Account Common Stock, $0.001 par value 177 D Common Stock, $0.001 par value 31 I By spouse Common Stock, $0.001 par value 30 I By Leder Laboratories, Inc. Common Stock, $0.001 par value 30 I By Starling Pharmaceuticals, Inc. Common Stock, $0.001 par value 205 I By Lederman & Co., LLC Common Stock, $0.001 par value 33 I By L&L Technologies, LLC Common Stock, $0.001 par value 59 I By Targent Pharmaceuticals, LLC The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $1.15 to $1.16, inclusive. The reporting person undertakes to provide to Tonix Pharmaceuticals Holding Corp., any security holder of Tonix Pharmaceuticals Holding Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Reporting person may be deemed to be a control person of this entity. /s/ Seth Lederman 2019-12-04